MIRM FY 2019 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$324,000

Operating Income

-$55M

Net Income

-$53M

EPS (Diluted)

$-2.29

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$147M

Total Liabilities

$16M

Stockholders' Equity

$130M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$324,000	$0	—
Operating Income	-$55M	-$3M	-1777.3%
Net Income	-$53M	-$17M	-202.9%